NEU: Das eBook.de Hörbuch Abo - jederzeit, überall, für nur 7,95 € monatlich!
Jetzt entdecken
mehr erfahren
Produktbild: The Prostate Cancer Dilemma
Produktbild: The Prostate Cancer Dilemma

The Prostate Cancer Dilemma

Selecting Patients for Active Surveillance, Focal Ablation and Definitive Therapy

(0 Bewertungen)15
eBook pdf
eBook pdf
85,49 €inkl. Mwst.
Sofort lieferbar (Download)
Empfehlen

This comprehensive text provides a complete description of the newest technologies to diagnose and manage the most common prostate cancer diagnosed today: low risk disease. The book reviews new data about genetic markers, transperineal mapping biopsy and mpMRI, how to apply each of these technologies in patients with elevated PSA, when a prior prostate biopsy performed by the standard TRUS method is negative, and, in cases where low risk disease is already diagnosed, how to differentiate those men who might harbor more aggressive disease from those who do not. Over 75% of newly diagnosed prostate cancer meets the criteria for low risk disease which has created a dilemma for both patients and clinicians because of the inaccuracy of the standard TRUS biopsy method. Active surveillance programs have been initiated and are reviewed. How the new technologies impact surveillance programs are addressed. Clinical stage designation is updated and a new intra-prostatic staging system is discussed. Prostate biopsy techniques utilizing transrectal ultrasound, transperineal mapping, elastography and mpMRI are compared. Finally, utilization of these new technologies in the application of focal therapy is reviewed.

The Prostate Cancer Dilemma will serve as a valuable resource for clinicians, surgeons and researchers with an interest in early prostate cancer. Chapters are written by experts in their fields and include the most up-to-date scientific and clinical information as well as links to procedural video content.

Inhaltsverzeichnis

Part One: Diagnosis. - History of PSA, from Detection to Over Diagnosis. - Pathology of Prostate Cancer: What has Changed in the Last 30 years? - Clinical Risk Prediction Tools for Prostate Cancer: TMN to CAPRA-Should Risk be Re-defined? - TRUS Biopsy: Is There Still a Role? - Transperineal Biopsy Technique. - 3D Biopsy: A New Method to Diagnose Prostate Cancer. - Elastography: Can it Improve Prostate Biopsy Results? - Multi parametric MRI of the Prostate as a Tool for Prostate Cancer Detection. - Genomic Markers. - Part Two: Treatment. - Current Status of Clinical Trials in Active Surveillance. - Focused targeted Therapy in Prostate Cancer. - Technologies and Methods in Primary Ablation with Focal Therapy. - Multi parametric MRI (mpMRI)-Guided Focal Therapy. - Conclusions.

Produktdetails

Erscheinungsdatum
19. Oktober 2015
Sprache
englisch
Auflage
1st ed. 2016
Seitenanzahl
206
Dateigröße
7,33 MB
Herausgegeben von
Nelson N. Stone, E. David Crawford
Kopierschutz
mit Wasserzeichen versehen
Produktart
EBOOK
Dateiformat
PDF
ISBN
9783319214856

Pressestimmen


The book will be of interest to both experienced
practitioners and trainees in urology, radiation oncology, medical oncology,
and interventional radiology. This is an outstanding, succinct, yet thorough
overview of current and leading-edge approaches to the diagnosis and management
of low-risk prostate cancer. This should be a valuable resource for those who
assist in the care of men with this common presentation of prostate cancer. (Mark
D. Hurwitz, Doody s Book Reviews, February, 2016)


Bewertungen

0 Bewertungen

Es wurden noch keine Bewertungen abgegeben. Schreiben Sie die erste Bewertung zu "The Prostate Cancer Dilemma" und helfen Sie damit anderen bei der Kaufentscheidung.